MISSION

Science
that becomes medicine

VISION

PrimeCell team is working 15 years to discover technologies
to treat unmedical needs of civilisation.

STRATEGY

PrimeCell is the bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cells parameters to support regeneration of human tissues and organs.

We are proud to our results
in regenerative medicine

Patients/year

SQM OF OUR LABS

RESEARCH PROJECTS

CORE EMPLOYEES

RESEARCH PLATFORM

NEWS

Zentiva získala od společnosti Primecell licenci k biologickým náplastem na chronické rány AMNIODERM

Společnost Zentiva získala od spin-off společnosti BioHealing ze skupiny Primecell licenci k bionáplastem AMNIODERM®, které bude marketovat na českém a evropském trhu. „Jsme rádi, že se tak významný výrobce léčiv, jakým[…]

Read more

GEN: Remescor, one of the options for COVID-19

18. 5. 2020 – Genetic Engineering & Biotechnology News (GEN) has ranked Remescor (Primecell drug development) into the group of candidates for COVID-19 treatment. More: https://www.genengnews.com/covid-19-candidates/primecell/

Read more

Co-operative transfer research

PrimeCell leads co-operative transfer research with prestigious Universities, Science institutions and technology companies around the world.